Table 2.
HLA DR allelic frequencies between RHD cases and non RHD controls
| Variable | Total (n,%) | Cases (n,%) | Controls (n,%) | P value | |
|---|---|---|---|---|---|
|
HLA |
DR1 |
45/199, 22.6% |
14/96, 14.6% |
31/103, 30.1% |
0.01 |
| |
DR3 |
18/199,9.04% |
7/96, 7.29% |
11/103, 10.7% |
0.4 |
| |
DR7 |
16/199, 8.04% |
11/96, 11.5% |
5/103, 4.9% |
0.1 |
| |
DR8 |
11/199, 5.53% |
4/96, 4.2% |
7/103, 6.8% |
0.34 |
| |
DR9 |
7/199, 3.52% |
4/96, 4.2% |
3/103, 2.9% |
0.36 |
| |
DR10 |
8/199, 4.02% |
6/96, 6.3% |
2/103, 1.9% |
0.13 |
| |
DR11 |
41/199,20.60% |
30/96, 31.3% |
11/103, 10.7% |
<0.001 |
| |
DR13 |
11/199, 5.53% |
4/96, 4.2% |
7/103, 6.8% |
0.47 |
| DR17 | 24/199,12.06% | 9/96, 9.4% | 15/103, 14.6% | 0.28 | |
HLA- Human leukocyte antigen.